Experts in healthcare reimbursement and regulation,
providing customized consulting
and education services.

Training Programs

We bring the experts to you with a range of on-site education options and bootcamp style programs that teach how a firm grasp of the rules leads to operational excellence.

More information »

Audits & Assessments

Our team of specialized regulatory specialists can assist your organization in revving up your revenue cycle by auditing and assessing key processes for coding and billing.

More information »

Regulatory Monitoring

Our team is available for ongoing regulatory watchdog services that answer your questions and offer you the latest Medicare news, analysis and operational guidance.

More information »

Jun
10

OIG issues report on NGS oxaliplatin claims, reiterates survey policy

Email This Post Print This Post

CMS reiterates policy on unannounced surveys

On June 5, CMS issued a memorandum in which it reiterated current policy that all surveys must be unannounced for all providers and suppliers, except for standard surveys of Clinical Laboratory Improvement Amendments (CLIA) laboratories and other limited exceptions.

View the memo.

OIG releases report on oxaliplatin claims processed by NGS

On May 27, the OIG issued a report on oxaliplatin claims processed in 2004 and 2005 by National Government Services (NGS), and Medicare fiscal intermediary. The OIG found that, for all 88 payments reviewed, 10 hospitals billed NGS for the incorrect number of service units of oxaliplatin. As a result, the hospitals received overpayments totaling $2.2 million during calendar years 2004 and 2005.

View the OIG report.

Leave a Reply